UBE2T and pancreatic neoplasm: 1,2,3,4,6-O-Pentagalloylglucose 18 is a naturally occurring galloyl-β-d-glucose compound that has emerged as a promising inhibitor of UBE2T, particularly in the context of pancreatic cancer treatment.